Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B and hepatitis E viruses represented a breakthrough in vaccine development. However, for dengue and COVID-19, technical complications, such as an incomplete understanding of the requirements for protecti...

Full description

Bibliographic Details
Main Authors: Simon Collett, Linda Earnest, Julio Carrera Montoya, Melissa A. Edeling, Ashley Yap, Chinn Yi Wong, Dale Christiansen, Jason Roberts, Jamie Mumford, Valerie Lecouturier, Vincent Pavot, Sergio Marco, Joon Keit Loi, Cameron Simmons, Shivali A. Gulab, Jason M. Mackenzie, Aaron Elbourne, Paul A. Ramsland, Garth Cameron, Dhiraj Hans, Dale I. Godfrey, Joseph Torresi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Microbiology
Subjects:
flavivirus
arbovirus
adjuvant
VLP
immunology
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1065609/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1065609/full

Similar Items